Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Gutmann

Showing results (1-10 of 434) with videos related to

Pageof 44
Sort By:
Cell|January 12, 2019
Clearing the Fog surrounding ChemobrainDavid H Gutmann
Expert Review of Neurotherapeutics|May 13, 2016
Exploring the genetic basis for clinical variation in neurofibromatosis type 1David H Gutmann
Neuro-Oncology Advances|June 10, 2024
Leveraging murine models of the neurofibromatosis type 1 cancer predisposition syndrome to elucidate the cellular circuits that drive pediatric low-grade glioma formation and progressionDavid H Gutmann
Molecular Therapy. Nucleic Acids|September 4, 2023
Putting a stop to nonsense: Revisiting gene correction therapy for neurofibromatosis type 1David H Gutmann
Journal of Child Neurology|October 31, 2002
Neurofibromin in the brainDavid H Gutmann
Oncoscience|January 17, 2015
The taxonomy of brain cancer stem cells: what's in a name?David H Gutmann
Neurology|July 1, 2014
Eliminating barriers to personalized medicine: learning from neurofibromatosis type 1David H Gutmann
Advances in Experimental Medicine and Biology|February 8, 2020
The Sociobiology of Brain TumorsDavid H Gutmann
Journal of Child Neurology|October 28, 2008
Using neurofibromatosis-1 to better understand and treat pediatric low-grade gliomaDavid H Gutmann
Brain Pathology (Zurich, Switzerland)|December 17, 2008
Modeling human brain tumors in miceDavid H Gutmann
Pageof 44

Showing results (1-10 of 434) with videos related to

Sort By:
Pageof 44
Cell|January 12, 2019
Clearing the Fog surrounding ChemobrainDavid H Gutmann
Expert Review of Neurotherapeutics|May 13, 2016
Exploring the genetic basis for clinical variation in neurofibromatosis type 1David H Gutmann
Neuro-Oncology Advances|June 10, 2024
Leveraging murine models of the neurofibromatosis type 1 cancer predisposition syndrome to elucidate the cellular circuits that drive pediatric low-grade glioma formation and progressionDavid H Gutmann
Molecular Therapy. Nucleic Acids|September 4, 2023
Putting a stop to nonsense: Revisiting gene correction therapy for neurofibromatosis type 1David H Gutmann
Journal of Child Neurology|October 31, 2002
Neurofibromin in the brainDavid H Gutmann
Oncoscience|January 17, 2015
The taxonomy of brain cancer stem cells: what's in a name?David H Gutmann
Neurology|July 1, 2014
Eliminating barriers to personalized medicine: learning from neurofibromatosis type 1David H Gutmann
Advances in Experimental Medicine and Biology|February 8, 2020
The Sociobiology of Brain TumorsDavid H Gutmann
Journal of Child Neurology|October 28, 2008
Using neurofibromatosis-1 to better understand and treat pediatric low-grade gliomaDavid H Gutmann
Brain Pathology (Zurich, Switzerland)|December 17, 2008
Modeling human brain tumors in miceDavid H Gutmann
Pageof 44